Arrhythmia Monitoring Devices Market Size & Share, by End user (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings & Individuals); Application; Product Type; Technology; Sales Channel - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2026-2035

Arrhythmia Monitoring Devices Market - Regional Analysis

North America Market Insights

North America is expected to grab the largest revenue share of 40.4% in the global market by the end of 2035. The strong adoption of innovative monitoring solutions and a growing awareness of cardiac health among the aging population are the key factors propelling this leadership. In February 2024, the NHLBI reported that it is launching targeted campaigns such as Yes, YOU! to raise heart disease awareness among younger women, particularly Black and Latina communities, to educate about risk factors and promote heart-healthy habits early in life, hence benefiting overall market upliftment.

The U.S. leads the regional arrhythmia monitoring devices market on account of significant investments in research and development and increasing healthcare costs. As per an August 2023 NIH article, hospitalizations drive the largest portion of the heart failure costs in the country, wherein outpatient visits and medications saw notable increases. Besides the HF-related expenses total is nearly USD 180 billion on a yearly basis, with incremental costs of USD 22.3 billion, hence suitable for market expansion.

Canada is also portraying steady growth in the market, which is supported by the increasing awareness of atrial fibrillation and other cardiac arrhythmias among both service providers and consumers. In April 2023, Icentia Inc. announced that it received FDA 510(k) clearance for CardioSTAT, which is a wireless, single-use continuous ECG monitoring device that offers flexible monitoring durations from 24 hours up to 14 days. The pay-by-duration model aims to provide cost-effective, adaptable cardiac care with streamlined data analysis options for healthcare providers.

Key U.S. Cardiovascular Disease Prevention Programs (2021-2023)

Source: CDC

APAC Market Insights

Asia Pacific is predicted to emerge as the fastest-growing region in the arrhythmia monitoring devices market from 2026 to 2035. This accelerated progression is readily propelled by the rapid urbanization and improving healthcare access. Besides, technological discoveries are at a surge, wherein the wearable ECG monitors and implantable devices are becoming extremely prevalent. Also, the increasing investment in healthcare infrastructure and a growing emphasis on preventive cardiac care are creating favorable conditions for market expansion.

China is maintaining a dominant position in the regional market, facilitated by the strong focus on healthcare modernization, research ecosystem, and digital transformation. For instance, in December 2023, Singular Medical launched the clinical trial for the country’s first domestically produced implantable cardiac monitor, called the SiLu ICM. The company also stated that the trial enrolled its first participant on the same day, marking a key milestone in China’s cardiac monitoring.

India is gaining enhanced traction in the arrhythmia monitoring devices market with the emergence of affordable diagnostic technologies and expanding healthcare access. The country also benefits from constant government and private organization efforts to strengthen cardiac care. The country’s Ministry of Health in September 2023 launched a nationwide campaign to raise awareness about hypertension and promote heart-healthy lifestyles. The initiative is backed by the Global Health Advocacy Incubator, which is a large-scale effort that emphasizes prevention, treatment, and community engagement to productively address cardiovascular diseases.

Cardiac Device Implantation Statistics in China (2022)

Source: APHRS

Europe Market Insights

Europe is retaining its position as the second-largest stakeholder in the arrhythmia monitoring devices market. This became possible with the increasing prevalence of cardiovascular diseases and aging populations across prominent countries such as Germany, the UK, and France. In this context, SJD Barcelona Children’s Hospital in January 2022 introduced the region’s first-ever implantable cardiac monitor with remote programming capabilities for long-term arrhythmia diagnosis in children. The organization also noted that this innovation enhances pediatric arrhythmia management by combining minimally invasive implantation with advanced digital connectivity.

Germany is representing itself as the key growth engine in Europe’s arrhythmia monitoring devices industry, fueled by a combination of advanced healthcare infrastructure and strong research and development activities. In April 2024, BIOTRONIK introduced its new BIOMONITOR IV insertable cardiac monitor at the EHRA Congress in Berlin, which also has an advanced AI-powered SmartECG technology. The company also proclaimed that the device reduces false positive arrhythmia detections, thereby providing high signal quality and reliable remote monitoring.

The arrhythmia monitoring devices market in Spain is continuously growing due to the increased adoption of innovative wearable technologies and AI-powered diagnostic platforms.  In this context, Philips in May 2024 stated that it successfully deployed its wearable ePatch and AI-powered Cardiologs analytics platform across 14 hospitals in the country. Also, this ambulatory cardiac monitoring solution enhances the detection of arrhythmias such as atrial fibrillation, thereby improving patient comfort and reducing hospital stays and expenses.